89bio Financial Statements From 2010 to 2025

ETNB Stock  USD 8.55  0.15  1.72%   
89bio financial statements provide useful quarterly and yearly information to potential 89bio Inc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on 89bio financial statements helps investors assess 89bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting 89bio's valuation are summarized below:
Market Capitalization
1.3 B
Earnings Share
(3.51)
We have found one hundred twenty available fundamental signals for 89bio Inc, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of 89bio Inc prevailing market performance against the performance between 2010 and 2025 to make sure the company can sustain itself in the future. The current year's Market Cap is expected to grow to about 773.8 M. The current year's Enterprise Value is expected to grow to about 656.4 M
Check 89bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 89bio's main balance sheet or income statement drivers, such as Tax Provision of 726.6 K, Depreciation And Amortization of 329.6 K or Selling General Administrative of 20.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.15. 89bio financial statements analysis is a perfect complement when working with 89bio Valuation or Volatility modules.
  
Check out the analysis of 89bio Correlation against competitors.

89bio Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets275.3 M478.7 M132.4 M
Slightly volatile
Other Current Liabilities11.8 M19.3 M6.9 M
Slightly volatile
Total Current Liabilities20.1 M36.1 M11.4 M
Slightly volatile
Property Plant And Equipment Net1.7 M1.6 M427 K
Slightly volatile
Accounts Payable16.2 M15.4 M4.8 M
Slightly volatile
Cash150.5 M126.1 M74.9 M
Slightly volatile
Non Current Assets Total1.1 M2.2 M554.9 K
Slightly volatile
Non Currrent Assets Other384.4 K640 K203.4 K
Slightly volatile
Other Assets302.9 K332.4 K153.8 K
Slightly volatile
Cash And Short Term Investments262 M440 M126.2 M
Slightly volatile
Common Stock Total Equity61.6 K58.6 K19.8 K
Slightly volatile
Common Stock Shares Outstanding110 M104.7 M25 M
Slightly volatile
Liabilities And Stockholders Equity275.3 M478.7 M132.4 M
Slightly volatile
Non Current Liabilities Total21.3 M41.8 M21.3 M
Very volatile
Capital Surpluse564.4 M537.5 M187.2 M
Slightly volatile
Other Current Assets38.3 M36.5 M7.8 M
Slightly volatile
Other Stockholder Equity1.3 B1.2 B300.1 M
Slightly volatile
Total Liabilities40.9 M77.9 M32.6 M
Slightly volatile
Property Plant And Equipment Gross1.7 M1.6 M427 K
Slightly volatile
Total Current Assets274.2 M476.4 M131.9 M
Slightly volatile
Capital Stock126 K120 K28.3 K
Slightly volatile
Net Working Capital254.1 M440.3 M120.4 M
Slightly volatile
Common Stock126 K120 K28.3 K
Slightly volatile
Property Plant Equipment131.1 K105.8 K74.3 K
Slightly volatile
Short Term Investments201.1 M313.9 M136.2 M
Slightly volatile
Deferred Long Term Liabilities320 K180 K481.2 K
Slightly volatile
Short and Long Term Debt Total1.7 M1.8 M17.7 M
Slightly volatile
Other Liabilities292.1 K576.1 K139.4 K
Slightly volatile
Long Term Debt26.7 M35.7 M19.4 M
Slightly volatile
Short and Long Term DebtM2.2 M2.5 M
Slightly volatile
Non Current Liabilities Other2.4 M4.4 M728.7 K
Slightly volatile
Short Term Debt957.2 K1.5 M2.1 M
Slightly volatile
Long Term Debt Total15.8 M17.7 M19.3 M
Slightly volatile

89bio Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization329.6 K313.9 K85.4 K
Slightly volatile
Selling General Administrative20.3 M39.6 M10.1 M
Slightly volatile
Other Operating Expenses182.6 M173.9 M57 M
Slightly volatile
Research Development362.3 M345 M72.6 M
Slightly volatile
Total Operating Expenses403.9 M384.7 M84 M
Slightly volatile
Reconciled Depreciation49.3 K38 K25.7 K
Slightly volatile
Cost Of Revenue329.6 K313.9 K91.6 K
Slightly volatile
Interest Income24.7 M23.6 M4.1 M
Slightly volatile
Selling And Marketing Expenses218.4 K245.7 K267.9 K
Slightly volatile

89bio Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation21.7 M20.6 M5.2 M
Slightly volatile
Other Cashflows From Financing Activities54.2 M51.7 M22.2 M
Very volatile
Capital Expenditures14.2 K15 K45 K
Very volatile
Issuance Of Capital Stock144.7 M157.6 M78.4 M
Slightly volatile
Total Cash From Financing Activities182.7 M218.6 M96 M
Slightly volatile
End Period Cash Flow118.3 M126.1 M60.1 M
Slightly volatile
Change To Netincome8.9 M9.3 M5.9 M
Slightly volatile
Cash And Cash Equivalents Changes3.1 M2.5 M4.2 M
Slightly volatile
Dividends Paid229.1 K241.2 K15 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Payables Turnover0.0150.02860.0118
Slightly volatile
Cash Per Share3.994.20155.2683
Slightly volatile
Days Payables Outstanding12.5 K13.2 K59.2 K
Slightly volatile
Income Quality0.661.0020.7833
Pretty Stable
Current Ratio10.8613.18757.9156
Slightly volatile
Capex Per Share1.0E-41.0E-40.0063
Slightly volatile
Debt To Assets0.00360.00381.2563
Slightly volatile
Days Of Payables Outstanding12.5 K13.2 K59.2 K
Slightly volatile
Long Term Debt To Capitalization0.00260.00270.099
Slightly volatile
Total Debt To Capitalization0.00430.00451.6381
Slightly volatile
Quick Ratio10.8613.18757.9156
Slightly volatile
Net Income Per E B T0.81.00190.9904
Slightly volatile
Cash Ratio3.313.48925.7834
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.11.01.0086
Slightly volatile
Debt Ratio0.00360.00381.2563
Slightly volatile

89bio Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap773.8 M737 M285.3 M
Slightly volatile
Enterprise Value656.4 M625.2 M241.8 M
Slightly volatile

89bio Fundamental Market Drivers

Cash And Short Term Investments440 M

89bio Upcoming Events

8th of March 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About 89bio Financial Statements

89bio stakeholders use historical fundamental indicators, such as 89bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although 89bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in 89bio's assets and liabilities are reflected in the revenues and expenses on 89bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in 89bio Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-654.3 K-687 K
Cost Of Revenue313.9 K329.6 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether 89bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of 89bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of 89bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on 89bio Inc Stock:
Check out the analysis of 89bio Correlation against competitors.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 89bio. If investors know 89bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 89bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.51)
Return On Assets
(0.45)
Return On Equity
(0.78)
The market value of 89bio Inc is measured differently than its book value, which is the value of 89bio that is recorded on the company's balance sheet. Investors also form their own opinion of 89bio's value that differs from its market value or its book value, called intrinsic value, which is 89bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 89bio's market value can be influenced by many factors that don't directly affect 89bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 89bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 89bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 89bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.